WO2008040765A1 - User interface for delivery system comprising diary function - Google Patents
User interface for delivery system comprising diary function Download PDFInfo
- Publication number
- WO2008040765A1 WO2008040765A1 PCT/EP2007/060511 EP2007060511W WO2008040765A1 WO 2008040765 A1 WO2008040765 A1 WO 2008040765A1 EP 2007060511 W EP2007060511 W EP 2007060511W WO 2008040765 A1 WO2008040765 A1 WO 2008040765A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- data
- user
- display
- view
- type
- Prior art date
Links
- 238000012384 transportation and delivery Methods 0.000 title claims description 24
- 239000003814 drug Substances 0.000 claims description 35
- 229940079593 drug Drugs 0.000 claims description 32
- 238000001802 infusion Methods 0.000 claims description 27
- 238000012377 drug delivery Methods 0.000 claims description 19
- 239000008280 blood Substances 0.000 claims description 16
- 210000004369 blood Anatomy 0.000 claims description 16
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 13
- 239000008103 glucose Substances 0.000 claims description 13
- 238000000034 method Methods 0.000 claims description 12
- 235000012054 meals Nutrition 0.000 claims description 11
- 230000008859 change Effects 0.000 claims description 9
- 238000013500 data storage Methods 0.000 claims description 6
- 238000013479 data entry Methods 0.000 claims description 2
- 230000006870 function Effects 0.000 description 29
- 238000004891 communication Methods 0.000 description 17
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 16
- 239000012530 fluid Substances 0.000 description 15
- 230000009471 action Effects 0.000 description 13
- 102000004877 Insulin Human genes 0.000 description 8
- 108090001061 Insulin Proteins 0.000 description 8
- 238000003780 insertion Methods 0.000 description 8
- 230000037431 insertion Effects 0.000 description 8
- 229940125396 insulin Drugs 0.000 description 8
- 230000002123 temporal effect Effects 0.000 description 6
- 230000004913 activation Effects 0.000 description 5
- 239000000843 powder Substances 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000000853 adhesive Substances 0.000 description 4
- 230000001070 adhesive effect Effects 0.000 description 4
- 230000002354 daily effect Effects 0.000 description 4
- 239000012528 membrane Substances 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 230000001681 protective effect Effects 0.000 description 3
- 229940000425 combination drug Drugs 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 230000008878 coupling Effects 0.000 description 2
- 238000010168 coupling process Methods 0.000 description 2
- 238000005859 coupling reaction Methods 0.000 description 2
- 238000013461 design Methods 0.000 description 2
- 238000007689 inspection Methods 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241001631457 Cannula Species 0.000 description 1
- 229910000831 Steel Inorganic materials 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000004397 blinking Effects 0.000 description 1
- 238000004364 calculation method Methods 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 206010061592 cardiac fibrillation Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000000599 controlled substance Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000002600 fibrillogenic effect Effects 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 230000014509 gene expression Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 230000003054 hormonal effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000000873 masking effect Effects 0.000 description 1
- 239000011159 matrix material Substances 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 230000003405 preventing effect Effects 0.000 description 1
- 238000009516 primary packaging Methods 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000001846 repelling effect Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000010959 steel Substances 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 239000012780 transparent material Substances 0.000 description 1
- 230000003442 weekly effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M5/00—Devices for bringing media into the body in a subcutaneous, intra-vascular or intramuscular way; Accessories therefor, e.g. filling or cleaning devices, arm-rests
- A61M5/14—Infusion devices, e.g. infusing by gravity; Blood infusion; Accessories therefor
- A61M5/168—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body
- A61M5/172—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic
- A61M5/1723—Means for controlling media flow to the body or for metering media to the body, e.g. drip meters, counters ; Monitoring media flow to the body electrical or electronic using feedback of body parameters, e.g. blood-sugar, pressure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/502—User interfaces, e.g. screens or keyboards
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/50—General characteristics of the apparatus with microprocessors or computers
- A61M2205/52—General characteristics of the apparatus with microprocessors or computers with memories providing a history of measured variating parameters of apparatus or patient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2230/00—Measuring parameters of the user
- A61M2230/20—Blood composition characteristics
- A61M2230/201—Glucose concentration
Definitions
- the present invention generally relates to electronically controlled drug delivery systems and devices.
- the invention relates to a medical delivery device in com- bination with a user operated interface for navigating a diary function of the delivery device, however, the different aspects of the present invention is applicable for all types of devices or systems for which a user has to store and display data.
- Drug delivery devices for delivering a drug such as insulin to a patient are well known and generally comprise a reservoir adapted to contain a liquid drug, a pump assembly for expelling a drug out of the reservoir to the patient.
- Such devices are often termed infusion pumps and are normally provided with a user interface allowing a user to control the operation of the pump.
- the user interface provided on some of the first pumps allowed the user to change a basal infusion rate and program a bolus infusion of a desired size.
- More recent infusion pumps have provided a number of more advanced features such as a number of basal rates to choose among, temporal basal, bolus calculations based on blood glucose (BG) input and/or meal size, diary functions, food data bases, connectivity to external devices, e.g. BG meter (BGM), PC, PDA or mobile phone.
- BG blood glucose
- An infusion pump may basically be a remotely controlled implantable pump or an external pump carried outside the human body and connected thereto by a transcutaneous access device such as a soft cannula or a needle.
- the external pump may be a traditional durable pump adapted to e.g. be worn in a belt at the waist of the user, this allowing the user to operate the pump by directly accessing the user interface on the pump, e.g. in order to change infusion rate or to program a bolus infusion.
- the pump may also be worn hidden under clothing this making operation more difficult.
- an infusion pump of the durable type with a wireless remote controller allowing the user to access some or all of the functionality of the pump, see for example US patent 6,551 ,276, US 2005/0022274 and US 2003/0065308, which are hereby incorporated by ref- erence, the latter disclosing an ambulatory medical device (MD) adapted to receive control messages from a communication device (CD).
- MD ambulatory medical device
- CD communication device
- traditional durable external pumps are relatively expensive it has been proposed to provide disposable pumps which may be attached directly to the skin of the user by means of an adhesive at a lower surface of such a device.
- a disposable pump may be provided to the user prefilled or it may be adapted to be filled by the user.
- the pump may be a unitary fully disposable device or it may comprise two or more portions adapted to be used for different periods of time.
- a remote controller would appear even more desirable as it would reduce the cost of providing a full user in- terface on the pump.
- EP 1 177 802 and US patent 6,740,059 which are hereby incorporated by reference, disclose semi-disposable and fully disposable infusion devices (which may be termed a local device or unit) which are intended to be operated primarily or entirely by a wireless remote controller (which may be termed a remote device or unit).
- the delivery device thus does not have to be provided with a user interface such as a dis- play and keyboard, the semi-disposable or disposable infusion can be provided more cost- effectively.
- a drug delivery system may be provided with a diary function allowing data to be stored, either automatically or by the user.
- a drug delivery system may be store infusion data such as bolus and temporal basal, blood glucose data such BG values and other data such as meal size and medicine taken.
- EP 1 494 158 discloses a system and method for managing presentation of medical data, involving presenting medical data, e.g. BG values, downloaded from a device in selected graphical display charts in visual display.
- US 2005/ 0022274 discloses a drug delivery system comprising a remote controller with a memory and display allowing the user to store and retrieve data, e.g. BG values which can be displayed either as values or as a graph for one or more days.
- the object of the present invention to provide a user interface and manner of presentation, as well as methods of operation, which assure one or more of the following: ease of retrieving stored data, easy to learn, intuitive and easy to use, fast to use, ease of entering data, and ease of navigating. It is a further object to provide a user interface including enhanced display/patient notification features, safety features, and/or medi- cal device programming/communication features.
- a device for displaying information comprising data storage means for storing data, display means adapted to display data to a user, processor means adapted to control the display means and the data storage means, and user input means.
- the processor means is adapted to store data organized as data units, each data unit comprising (i) time data, (ii) type data, and (iii) information data.
- the processor means is further adapted to control the display means to (a) graphically display an aggregate period view comprising at least two period views, (b) graphically display a single period view, (c) graphically display a data type symbol corresponding to a given data type, (d) graphically display at least one data type symbol for every period view, and (e) display a card view comprising information data corresponding to a selected data type symbol.
- the user input means allows the user to (1 ) select a desired period view from an aggregate period view, the display means thereby displaying the selected period view, and (2) select a desired symbol from the selected period view, the display means thereby displaying a card view showing at least a portion of the corresponding information data.
- a data display user interface is created providing the user with both an overview of stored data, yet allows the user to easily navigate to retrieve more detailed data information as desired, e.g. the aggregate period view may represent a 7, 5 or 3 days and the period view represent a day or a given number of hours.
- the display may also be adapted to display one or more symbols corresponding to a time line.
- the device for displaying information in accordance with the invention may have many different configurations.
- the device may be a stand-alone device adapted primarily for storing or displaying information, or it may be provided as part of a device providing further functions, e.g. a drug delivery device, a remote controller for a drug delivery system, a blood glucose meter, a mobile phone, or a PDA to mention some exemplary embodiments.
- the present invention may also be implemented in a handheld or stationary computer device, e.g. in a PC.
- the user input means may allow the user to select a card view showing information data of the next or the previous data unit stored in the storage means, the order of the data units being defined by the corresponding time data for the data units.
- the display means may be adapted to display a view menu allowing a user to select between two or more types of symbols or combinations of symbols (e.g. for a BG value and a bolus value) to be displayed for a given aggregate period view or a period view.
- the user input means may then allow the user, for the selected type of symbol or combination of symbols, to select a card showing information data of the next or the previous data unit stored in the storage means, the order of the data units being defined by the corresponding time data for the data units.
- the user input means allows the user to select a first mode in which selected data can be displayed, and a second mode in which data items can be en- tered using the user input means.
- the display means may be adapted to display a data entry menu allowing a user to select between two or more types of data, the selected type of data allowing the user to enter data corresponding to the selected type.
- the input means may be adapted to allow the user to select a period from a displayed aggregate period view, the selected period at least partially determining the time data for the data to be entered, this pre- venting that the user has to fully enter time data for a given action.
- the data unit comprises data from one or more of the following groups of data: (a) type data representing a blood glucose value, time data representing a point of time, and information data representing a blood glucose value, (b) type data repre- senting a meal, time data representing a point of time, and information data representing a value representing a characteristic of the meal, (c) type data representing a bolus delivery, time data representing a point of time, and information data representing a size of a bolus, (d) type data representing exercise, time data representing a point of time, and information data representing a value representing the level of exercise, (e) type data representing one of a change in a basal delivery rate, taking of medication, or illness, and time data representing a point of time.
- Each type data may be associated with a different graphical symbol adapted to be displayed on the display means.
- a drug delivery system comprising a device for displaying in- formation as described above, a reservoir adapted to contain a drug, an expelling assembly adapted for cooperation with the reservoir to expel drug out of the reservoir, and at least one processor adapted to control the expelling device in accordance with a programmed infusion profile.
- the system may comprises one or more processors wherein the different tasks of supporting the user interface and controlling the delivery means may be performed by a single processor or two or more processors in combination.
- processor covers any combination of electronic circuitry suitable for providing the specified functionality, e.g. processing data and controlling memory as well as all connected input and output devices.
- a processor will typically comprise one or more CPUs or microprocessors which may be supplemented by additional devices for support or control functions.
- the transmitter and receiver may be fully or partly integrated with a processor, or may be provided by individual units.
- Each of the components making up the processor circuitry may be special purpose or general purpose devices.
- data storage means covers any combination of electronic circuitry suitable for providing data storage.
- display means covers any type of display capable of visually providing a user with the specified functionality, e.g. a LCD or OLED.
- the system may comprise a delivery unit in which the reservoir and the expelling assembly are arranged, and a control unit comprising the display and user input means, the delivery and control units being adapted to communicate with each other, e.g. by wire, RF or IR.
- the system comprises a delivery unit in which the reservoir and the expelling as- sembly are arranged, the delivery unit further comprising the display and user input means.
- the drug may be in the form of a fluid drug or a powder drug.
- the expelling assembly may be in the form of a pump forcing or drawing drug from the reservoir and into a patient through a transcutaneous access device.
- the expelling assembly may also be semi-automatic dispensing a given amount of drug from a reservoir after which a flow of air created by the person using the system will transport the powder drug to the desired location, e.g. the lungs or other portion of the airways.
- the reservoir for a fluid drug may be any suitable structure adapted to hold an amount of a fluid drug, e.g. a hard reservoir, a flexible reservoir, a distensible or elastic reservoir.
- the reservoir may e.g. be prefilled, user fillable or in the form of a replaceable cartridge which again may be prefilled or fillable.
- the reservoir may also be in the form of a pressurized aerosol container.
- the reservoir may in the form of a blister or a plurality of individual blisters.
- the system may comprise or be adapted to cooperate with a transcutaneous access device which may e.g. be in the form of a hollow steel needle, a soft cannula in com- bination with an external or internal introduction needle, or a micro-needle array.
- the system may further comprise a transcutaneous device unit comprising a transcutaneous access device, and a mounting surface adapted for application to the skin of a subject, wherein the transcutaneous device unit and the delivery unit are adapted to be secured to each other to form a combined device.
- the user input means may be in the form of a keyboard comprising one or more user accessible keys, however, alternative a touch display or voice recognition may be used.
- the user input means may allow a user to e.g. bi-directionally scroll between period views from an aggregate period view, or enter data information by using bi-directional dial up and down keys.
- the user input means may also be provided by a four-way rocker switch or a four-way joystick, this allowing bi-directionally scrolling or setting of values in two directions or for two different types of input.
- a method for displaying information comprising the steps of (A) storing data as data units, each data unit comprising (i) time data, (ii) type data, and (iii) information data, (B) providing display means adapted to (a) graphically display an aggregate period view comprising at least two period views, (b) graphically display a single period view, (c) graphically display a data type symbol corresponding to a given data type, (d) graphically display at least one data type symbol for every period view, and (e) display a card view com- prising information data corresponding to a selected data type symbol, (C) selecting a period view from an aggregate period view, the display means thereby displaying the selected period view, and (D) selecting a symbol from the selected period view, the display means thereby displaying a card view showing at least a portion of the corresponding information data.
- the term "fluid drug” is meant to encompass ⁇ M ⁇ Cdfug-containing Tiowabie medicine capable of being passed through a delivery means such as a cannula, hollow needle or inhalation conduit in a controlled manner, such as a liquid, solution, gel, fine suspension or a powder.
- Representative drugs include pharmaceuticals such as peptides, proteins, and hormones, biologically derived or active agents, hormonal and gene based agents, nutritional formulas and other substances in both solid (dispensed) or liquid form.
- the term "subcutaneous” infusion is meant to encompass any method of transcutaneous delivery to a subject.
- fig. 1 shows a user input device in the form of a remote control (RC)
- figs. 2A and 2B show shortcut menu (SM) respectively main menu (mm) screens for a RC
- figs. 3A and 3B show a flowchart for a RC user interface architecture
- figs. 4A and 4B show different paths to an "edit bolus" menu
- figs. 5A and 5B show use of the build-in BG meter in order to enter a bolus
- fig. 6 shows temporal basal (TB) options by which the user can set or cancel a TB
- figs. 7A and 7B show how the user can view, edit or redefine the basal rate (BR), figs.
- BR basal rate
- figs. 9A-9C show the options available to the user for the reminder function
- fig.10 shows the options available to the user for the statistics function
- figs.11 A and 11 B show the different set-up options
- fig. 12 shows a dual-mode bolus input screen
- fig. 13 shows how a TB rate is programmed using a dual-mode screen
- fig. 14 shows a status screen indicating that both a bolus and a TB rate are being delivered
- figs. 15-18 show further types of dual-mode screens
- figs. 19-23 show aspects of the diary function
- fig. 24 shows the patch unit of fig. 5 in greater detail, fig.
- fig. 25 shows the patch unit of fig. 7 in an actuated state
- fig. 26 shows a patch unit with a pump unit partly attached
- fig. 27 shows the pump unit of fig. 9 fully attached to the patch unit
- fig. 28 shows in an exploded view a pump unit
- fig. 29 shows a schematic representation of a process unit and a control unit.
- the present invention relates to a user input device adapted to cooperate with a drug deliv- ery device (e.g. a drug delivery pump) in a drug delivery system.
- a drug deliv- ery device e.g. a drug delivery pump
- Fig. 1 shows a user input device 1 in the form of a remote control (RC) comprising an LCD display 30 arranged at the upper portion of the unit and buttons arranged beneath the display.
- the remote comprises a rocker switch 10 and a left ACCEPT key 21 as well as a right ESCAPE key 22.
- the rocker switch is the fundamental navigation button and is a four-way switch having four areas 11, 12, 13, 14 supporting respectively the directions: UP-DOWN and LEFT-RIGHT. Indeed, the four areas of the rocker switch may be replaced with a number of keys arranged in any desired configuration.
- the vertical axis functions to e.g. (i) scroll up/down in a menu, and (ii) increase or decrease a number.
- the horizontal axis LEFT RIGHT is used for e.g. (i) scrolling in time, and (ii) changing time related or secondary parameters.
- the accept button is the fundamental "Yes” button and functions as (i) go forth, enter, select, accept or confirm, and (ii) zoom-in in views.
- the Escape button is the fundamental "No” button and has the functions (i) no, escape, step back, exit or undo, and (ii) zoom-out in views. Additional func- tions may be added to the ones described.
- the display is a dot matrix display and may be a monochrome, greyscale or colour display. The display shows the main screen (MS) which normally is displayed when the RC is turned on.
- the MS serves to indicate to the 'user the status of the system controlled by the RC.
- the screen has a general configuration also used in many other situations of use (see below). More specifically, the MS comprises a central "split screen" area with left and right portions 31, 32 as well as an upper and a lower information bar 33, 34. In the shown view the MS displays in the upper bar the remaining amount of
- RECTIFIED SHEET (RULE 91) ISA/EP insulin in the insulin pump to which the RC is currently paired as well as the battery status for the RC.
- the split screen shows the current time and date, and the lower bar shows the current basal infusion rate for the paired pump.
- the split screen can have a "dual mode" configuration (see below) used for a number of input screens.
- status indication for an ongoing bolus and/or an ongoing temporal basal infusion rate may be displayed, e.g. status indication for an ongoing bolus and/or an ongoing temporal basal infusion rate.
- the RC is further provided with an upper port 40 for a build-in BG meter allowing a BG strip to be inserted and a BG value to be determined.
- the RC may further be provided with one or more keys at e.g. the sides allowing less commonly used functions to be activated, e.g. on- off and keyboard lock.
- the RC may be powered by replaceable or rechargeable batteries.
- the shortcut menu type of fig. 2A may be used also for one or more sub- levels of menus, e.g. the four menu items of fig. 2B may be displayed corresponding to fig. 2A. One or more of the four sub-level shortcut menus may then be provided with a further level of shortcut menus.
- the four-way rocker switch and the SM screen represents a concrete embodiment of a user input device in which a display is adapted to simultaneously display a plurality of menu items having a predefined location on the display means, and user input means al- lowing a user to directly select each of the simultaneously displayed menu items.
- the present user interface provides a high degree of user friendliness by combining the menu selection means (e.g.
- the rocker key with a second user interface in which the display means is adapted to display at least one user settable drug delivery parameter, wherein the user input means comprises a keyboard comprising at least one pair of user input keys, each pair allowing a user to bi-directionally set a user settable drug delivery parameter when user controllable settings are displayed.
- Fig. 3 shows an embodiment for a general user interface (Ul) architecture for the remote controller (RC).
- the Ul has a main screen (MS) which normally is displayed when the RC is turned on.
- the MS may be the standard MS or it may show additional information relating to an ongoing bolus or temporal basal (TB) rate.
- TB temporal basal
- the RC is switched on for the first time, the user is guided to the initial setup menu. From the MS the user can by pressing any key go to the shortcut menu (SM) from which the specific main functions can be chosen, either directly or via a main menu (MM).
- SM shortcut menu
- MM main menu
- an ongoing bolus or TB rate will influence the options in the SM.
- fig. 4 shows how the user can be guided to the "edit bolus" menu in three different ways: (1 ) after having determined a blood glucose value (BG) using the RC strip port (or alternatively by an external BG meter), (2) directly by the user, or (3) by using the bolus calculator (selected via the MM). In addition, a running bolus can be aborted.
- BG blood glucose value
- Fig. 5 shows how the build-in BG meter is used and how it can be used to enter the bolus menu.
- a BG strip When a BG strip is inserted the user is asked for calibration and type data, however, with no input the RC swiftly proceeds to the "request blood". If a sufficient amount of blood is placed on the strip and a BG within the set normal range is produced and displayed, the user is offered the option to go to the bolus calculator or leave the BG menu. If the bolus option is chosen the user is requested to enter meal carbohydrates (if any) and the RC will calculate and display a suggested bolus size. The user can then use this information as guidance when freely setting a bolus of a desired size.
- Fig. 6 shows the two TB options by which the user can set or cancel a TB. How to set a temp basal is described below with reference to fig. 13.
- Figs. 7A and 7B show how the user can either: (1 ) view the basal rate (BR) profile, (2) edit the BR profile, or (3) redefine the BR profile.
- the disclosed system uses a 7-day BR profile which is set for the first time during the initial set- up. Via the "edit BR profile" function the user can select a single day and change the BR profile of that day. Alternatively, the user can decide to re-set the entire 7-day profile. If the profile is the same for every day, once the first (e.g. Monday) BR profile is entered, the user can copy the profile for the subsequent days. How to set a daily BR profile is described below with reference to figs. 17 and 18.
- Fig.8 shows the options available to the user for the diary function.
- the display opens with a 7-day view showing a pre-selected type of information, e.g. BG values, or combination of types of information, e.g. BG values and bolus.
- BG values a pre-selected type of information
- each event is represented by a specific icon.
- the user now has to two options, either to select another type of information to be displayed or select a day view showing essentially the same information but in a higher resolution over the 24 hours of the day.
- the user can also select a different type of information when in the day view state.
- the user can select any of the displayed icons by browsing and then request the associated detailed information to be displayed in an "action card" view.
- an action card When an action card is displayed the user can browse through the previous or next card for the selected type of infor- mation, both for the selected day but also for the previous or subsequent day.
- a given action card When a given action card is selected the user can choose (if allowed) between different options for the displayed information: edit, delete or hide.
- edit, delete or hide In the "add” option the user selects a day and a type of information.
- the user is then presented with an "edit action card” view allowing the user to enter the relevant type of information for the selected type of information, e.g. meal size and time.
- Fig. 9 shows the options available to the user for the reminder function.
- the reminder function works essentially the same way as the diary function, i.e. the user is presented with week view, day view and "reminder card" (instead of action card) options as well as type of reminders.
- the user can edit and add reminders as set out above for the action card information.
- the user has a recurrence option, i.e. daily or weekly.
- Fig.10 shows the options available to the user for the statistics function.
- the statistics func- tion can display one or more average values, e.g. for 14 or 30 days, for a selected type of information, e.g. daily basal or daily bolus.
- Fig.1 1 shows the different options available to the user for the setup function, e.g. time and date, regional settings and alarms.
- the pump is controlled via the RC, this allowing new settings to be transmitted to the pump, however, the communication is two-way allowing also the pump to transmit information to the RC, e.g. alarms. Especially for the latter, it is important that communication is upheld between the two units.
- a first predetermined amount of time e.g. 10 minutes
- a first "connection lost" warning will appear in the main screen.
- a second predetermined amount of time e.g. 2 hours
- a second "connection lost" warning will appear in the main screen and an audible and/or tactile alarm will be sounded.
- the bolus menu point in the SM is selected by using the UP key which brings the user to the set bolus input screen which is of the "dual mode" configuration, see e.g. fig. 13.
- a dual mode screen displays two user controllable settings, e.g. two parameters, which at the same time (i.e. using the same screen) can be directly set by the user using a keyboard provided on the remote.
- a four-way rocker switch is provided allowing two settings 65, 66 to be controlled in an "up-down" or scrolling fashion.
- two set of arrows 36, 37, 38, 39 are provided to assist the user when operating the four-way switch.
- the display further comprises an upper and a lower bar for additional information.
- the bolus input screen in fig. 12 shows to the left a numerical value (initially showing 0.0) indicating the selected amount of e.g. insulin unit and associated with a set of UP-DOWN arrows. To the right is shown a symbol indicating the selected type of bolus infusion, e.g. "direct” (e.g. as fast as possible), "extended” or “sawtooth” (also called dual-phase), and an associated set of LEFT-RIGHT arrows.
- direct e.g. as fast as possible
- sawtooth also called dual-phase
- Fig. 13 shows another use of the dual-mode screen in which a TB rate is programmed. More specifically, the TB input screen shows to the left a numerical % value 65 (initially showing 0%) indicating the selected percentage adjustment of the running basal rate or profile, and an associated set of UP-DOWN arrows. To the right is shown the selected duration of time 66 for the TB expressed in hours and minutes, and an associated set of LEFT-RIGHT arrows. As follows, when setting a TB rate the user enters the percentage adjustment, selectable from e.g. (-100) % to (+100) % as well as the desired time period for the TB rate.
- figs. 15-18 show further types of dual-mode screens.
- the user is brought to a "define profile" screen.
- a "week view” screen for the BR profile see fig. 15.
- This screen comprises two sets of arrows, a first set being used in a "spinner bar” 35 arranged below the upper information bar, the second set being used for a given selected day.
- spinner bar a “spinner bar” 35 arranged below the upper information bar
- the second set being used for a given selected day.
- the edit BR profile screen is adapted to graphically display an infusion profile showing an infusion rate as a function of time.
- the profile comprises a number of consecutive segments, each segment indicating a period of time and an associated infusion rate (BR).
- BR infusion rate
- 24 segments are used for a 24 hours period and the profile is shown as a full line.
- the screen further shows an indicator 61 (here a circle with a dot) arranged corresponding to a given infusion rate for a given point of time, initially a time 0 and indicating an infusion rate of 0.
- the indicator is associated with two sets of arrows indicating that the indicator can be moved up-down corresponding to a desired BR as well as forth-back corresponding to a desired segment, i.e. desired point of or time.
- the RC is thus provided with first user input means allowing the user to move the indicator corresponding to a desired point of time, and second user input means allowing the user to move the indicator corresponding to a desired infusion rate, whereby the user graphically can draw a continuous profile 62 for a desired period of time by moving the indicator on the screen corresponding to the desired period of time, the drawn profile graphically displaying the BR profile.
- the actual time and BR corresponding to the indicator is shown in the lower bar.
- the BR profile is defined as a 7-day profile.
- accept of the profile will bring the user to a screen for the next day showing a "pre-set" identical profile which can then be accepted (and so forth until completion of the week), this being expedient as the profile is often the same for a number of day or even all 7 days of the week.
- the user simply start to redraw a new profile or change the profile for the previous day.
- the user selects the diary function which via a view/add "di- ary-options" menu brings the user to the "diary - week view” screen, see fig. 19.
- This screen is similar to the above-described week view for the basal profile, see fig. 15, i.e. comprising a spinner bar and week view 67 with selectable days, both being selectable using the two sets of keys provided by the 4-way rocker key.
- the UP-DOWN keys the user can select between the following diary item options to be displayed: Blood glucose (BG), BG and bolus (see fig. 20), BG and basal (i.e. BR profile), and miscellaneous.
- the diary item options can represent either a single type of data, e.g. BG, or a combination of one or more data types, e.g. BG and basal.
- the miscellaneous item can comprise a number of data types, e.g. meal, medication or exercise.
- the user can select a day view 68, see fig. 21. Both in the week and day view the individual data units are represented by a symbol 63, e.g. for BG a drop or blood, or for basal a change in the displayed profile.
- the LEFT-RIGHT keys allowing the user to scroll back and forth to previous or next symbol, this including the symbols of the "neighbouring" days.
- the ACCEPT key for a given selected symbol, the user is brought to a "diary action card" screen 69 displaying data associated with the selected symbol, see fig. 22.
- a given symbol and its associated data can be considered a data unit which may comprise data from one of the following groups of data: (i) a symbol representing a blood glucose value, time data representing a point of time, and a blood glucose value, (ii) a symbol representing a meal, time data representing a point of time, and a value representing a characteristic of the meal, (iii) a symbol representing a bolus delivery, time data representing a point of time, and a size of a bolus, (iv) a symbol representing exercise, time data representing a point of time, and a value representing the level of exercise, and (v) a symbol representing one of an amount of change in a basal delivery rate, taking of medication, or illness, and time data representing a point of time.
- the "diary action card” screen comprises a spinner bar, this allowing the user to toggle between "edit”, “de- lete”, and “hide/show”.
- the type of data e.g. some kind of data cannot be deleted or edited.
- the user is brought to a week view screen similar to the screen for the view option, e.g. comprising a spinner bar and a day se- lector feature.
- a day and a type of data is selected from the spinner bar
- pressing the ACCEPT key takes the user directly to an action card edit screen corresponding to the selected type of data to be entered, see fig. 23 showing how a level and a time is entered for an exercise item to be added.
- aspects of the present invention may be used with programmable ambulatory insulin infusion pumps of the sort currently commercially available from a number of manufacturers, including without limitation and by way of example, Medtronic MiniMed under the trademark PARADIGM, lnsulet Corporation under the trademark OmniPod, Smiths Medical under the trademark Deltec COZMO, and others, these pumps either being provided with a remote control or being adaptable to be used with one.
- Medtronic MiniMed under the trademark PARADIGM
- lnsulet Corporation under the trademark OmniPod
- Smiths Medical under the trademark Deltec COZMO
- Fig. 24 shows a skin-mountable device in the form of a patch (or cannula) unit 400.
- the patch unit comprises a relatively rigid body portion 414 arranged on a flexible sheet member 430 with a lower mounting surface 431 provided with an adhesive allowing the sheet to be adhered to a skin surface of a subject.
- the sheet member comprises a central opening 432 through which a cannula can be inserted.
- the body portion comprises a housing portion 412 in which a cannula inserting mechanism is arranged, see below.
- the body portion further comprises two slider leg members 413 extending from the housing, the legs adding stiffness to the patch and further serves as guiding means when a pump/reservoir unit is attached the patch unit, see below.
- the housing is provided with a set of opposed grooves 420 serving as attachment means for a packaging and subsequently for a pump unit.
- the housing further comprises a fluid inlet 415 adapted to be mounted in fluid communication with a corresponding fluid outlet from an attached pump unit 450, an actuator 416 for actuating an electrical contact on the attached pump, and a release member 417 adapted to release a cannula inserting mechanism when the pump unit is attached for the first time, the cannula being inserted through the opening 432.
- the housing portion 412 also comprises a catch 419 adapted to engage a corresponding coupling structure on the pump unit. As appears, when the cannula 951 is inserted (see fig. 25), it is protected by the pump unit, however, the pump unit can be removed for subsequent inspection of the insertion site as shown in fig. 26.
- Fig. 26 shows an alternative embodiment of a patch unit 1010 with a pump unit 1050 by its side
- fig. 27 shows the pump unit fully but releasably attached.
- fig. 26 shows an embodiment of a medical device 1000, comprising a cannula unit 1010 of the type shown in fig. 24 and a thereto mountable pump (or reservoir) unit 1050.
- the cannula unit comprises a housing 1015 with a shaft into which a portion 1051 of the pump unit is inserted.
- the shaft has a lid portion 1011 with an opening 1012, the free end of the lid forming a flexible latch member 1013 with a lower protrusion (not shown) adapted to engage a corresponding depression 1052 in the pump unit, whereby a snap- action coupling is provided when the pump unit is inserted into the shaft of the cannula unit. Also a vent opening 1054 can be seen.
- the housing 1015 is provided with a pair of opposed legs 1018 and is mounted on top of a flexible sheet member 1019 with a lower adhesive surface 1020 serving as a mounting surface, the sheet member comprising an opening 1016 for the cannula 1017.
- the cannula from the housing of the cannula unit extends a cannula at an inclined angle, the cannula being arranged in such a way that its insertion site through a skin surface can be inspected (in the figure the full cannula can be seen), e.g. just after insertion.
- the opening in the lid provides improved inspectability of the insertion site.
- a drug delivery device which has a transcutaneous device, e.g. a soft can- nula as shown, which is very well protected during normal use, however, which by fully or partly detachment of the pump unit can be inspected as desired.
- a given device may be formed in such a way that the insertion site can also be inspected, at least to a certain degree, during attachment of the pump, e.g.
- the attached pump provides a high degree of protection during use irrespec- tive of the insertion site being fully or partly occluded for inspection during attachment of the pump.
- an inclined cannula is used, however, in alternative embodiments a needle or cannula may be inserted perpendicularly relative to the mounting surface.
- Fig. 28 shows in an exploded view a pump unit 300 of the same type as in fig. 12.
- the pump unit comprises an upper housing portion 310 and a lower housing portion 320 which in an assembled state provides a water-protected enclosure for the additional components of the reservoir unit: A pump assembly 330, an actuator 340, a reservoir 350, and electronic control means 360.
- a protective cap assembly 370 is at- tached to the unit.
- the lower housing portion is made from a transparent material allowing a reservoir (see below) to be inspected by a user from the outside, and comprises an opening 321 in which a water repelling vent 322 is arranged.
- a sheet member 325 with a window opening 326 is attached to the lower surface of the lower housing portion, this masking the transparent portion except for a window over the reservoir.
- the sheet member may be used to display user information, e.g. type and amount of drug.
- the pump assembly 330 is in the form of a membrane pump comprising a piston-actuated pump membrane with flow-controlled inlet- and outlet-valves.
- the pump has a general lay- ered construction comprising a number of body members between which are interposed flexible membrane layers, whereby a pump chamber, inlet and outlet valves, and one or more safety valves can be formed, the layers being hold together with clamps 338.
- the pump further comprises a fluid connector 335 in the form of hollow connection needle slidably positioned within the pump (for illustrative purposes shown outside of the pump), this allowing the pump to be connected with reservoir when the protective cap assembly 370 is activated.
- WO 2006/089958 for a more detailed description of such a membrane pump reference is made to applicants co-pending application WO 2006/089958, which is hereby incorporated by reference.
- the pump actuator is in the form of a coil actuator to which the pump assembly is attached by a clamp.
- a coil actuator to which the pump assembly is attached by a clamp.
- the drug reservoir is in the form of a flexible, pre-filled collapsible pouch 350 comprising a needle-penetratable septum 354 allowing the fluid connector to be pushed into the reservoir without leakage, thereby providing a fluid communication with the pump.
- a clip holder 352 is attached to the reservoir, this allowing the reservoir to be attached to the housing without influencing the reservoir per se.
- Under the reservoir (as seen from the lower surface of the unit) is arranged a sheet (not shown) comprising a contrast-enhancing pattern, e.g. a black line on a white background, allowing for easier visual identification of impurities in the drug, e.g. fibrillation in insulin.
- the electronic control means 360 comprises a PCB or flex-print 362 with a processor 361 for controlling the pump assembly, a battery 366, an acoustic transducer 365 providing an alarm and communication interface with the user, as well as a contact mounted on the actuator al- lowing the control means to be activated by the user when taken into use for the first time
- the control means may comprise a receiver and/or a transmitter allowing the reservoir to communicate wirelessly with a remote controller.
- the protective cap assembly 370 comprises an attachment member 371 initially locked to the reservoir unit and an activation "push button” member 372 slidingly attached to the attachment member.
- the reservoir unit is removed from its primary packaging (not shown) the user depresses the activation member towards the reservoir unit.
- This actuation results in three actions taking place: A first protrusion on the activation member will actuate a contact on the reservoir unit, this activating the electronics, and a second protrusion will engage the pump assembly and push the fluid connector 335 out from the pump assembly and into the reservoir, thereby establishing a fluid communication between the reservoir and the pump.
- depression of the activation member will "unlock" the attachment member and allow it, and thereby the activation member, to be removed from the reservoir unit. Thereafter the reservoir unit can be connected to the patch unit.
- Fig. 29 shows a schematic representation of a process unit 200 (here corresponding to the pump unit 1050 of fig. 26) and a controller unit 100 (here in the form of a wireless "remote controller” or “external communication device” for the pump unit). It is considered that the general design of such units is well known to the skilled person, however, for a more detailed description of the circuitry necessary to provide the desired functionality of the present invention reference is made to US 2003/0065308 which is hereby incorporated by reference.
- fig. 29 depicts a simplified block diagram of various functional components or modules (i.e. single components or groups of components) included in the pump unit 200 and remote controller 100.
- the remote controller unit includes a housing 101 , a remote processor 1 10 including a CPU, memory elements for storing control programs and operation data and a clock, an LCD display 120 for providing operation for information to the user, a keypad 130 for taking input from the user, an audio alarm 140 for providing information to the user, a vibrator 150 for providing information to the user, a main battery 160 for supplying power to the controller, a backup battery 161 to provide memory maintenance for the controller, a remote radio frequency (RF) telemetry transmitter 170 for sending signals to the pump unit, a remote radio frequency (RF) telemetry receiver 180 for receiving signals from the pump unit, and a second transmitter 190.
- RF radio frequency
- the controller further comprises a port 185, e.g. an infrared (IR) or RF input/output system, or a USB port for communicating with a further de- vice, e.g. a blood glucose meter (BGM), a continuous blood glucose meter (CGM) 1 a PC or a PDA.
- a port 185 e.g. an infrared (IR) or RF input/output system, or a USB port for communicating with a further de- vice, e.g. a blood glucose meter (BGM), a continuous blood glucose meter (CGM) 1 a PC or a PDA.
- a port 185 e.g. an infrared (IR) or RF input/output system
- a USB port for communicating with a further de- vice, e.g. a blood glucose meter (BGM), a continuous blood glucose meter (CGM) 1 a PC or a PDA.
- BGM blood glucose meter
- the pump unit 200 includes a housing 201 , local processor elec- tronics 210 including a CPU and memory elements for storing control programs and operation data, battery 260 for providing power to the system, a process unit RF telemetry transmitter 270 for sending communication signals to the remote unit, a process unit radio frequency (RF) telemetry receiver 280 for receiving signals from the remote unit, a second process unit receiver 240 (which may be in the form of a coil of an acoustic transducer used in an audio alarm for providing feedback to the user), a reservoir 230 for storing a drug, and a pump assembly 220 for expelling drug from the reservoir through a transcutaneous device to the body of a patient.
- local processor elec- tronics 210 including a CPU and memory elements for storing control programs and operation data
- battery 260 for providing power to the system
- a process unit RF telemetry transmitter 270 for sending communication signals to the remote unit
- RF radio frequency
- second process unit receiver 240 which may
- the pump unit may also comprise an LCD display for providing information to the user, a keypad for taking input from the user, and a vibrator or other tactile actuator for providing information to the user.
- RF transmission may be in accordance with a standard protocol such as Bluetooth ®.
- the system of fig. 29 comprises first and second means of communication allowing a first and second group of data types to be transmitted between the two units. In this way different properties of the two means of communication can be used to secure that certain data, e.g. during pairing of the two devices using near-field communication, can be transmitted in a more con- trolled way whereas other data can be transmitted in a less controlled way using longer- distance communication.
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Infusion, Injection, And Reservoir Apparatuses (AREA)
Abstract
Description
Claims
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN200780037318.5A CN101541360B (en) | 2006-10-04 | 2007-10-03 | User interface for delivery system comprising diary function |
US12/443,868 US8506524B2 (en) | 2006-10-04 | 2007-10-03 | User interface for delivery system comprising diary function |
JP2009530879A JP2010506279A (en) | 2006-10-04 | 2007-10-03 | Administration system user interface with diary function |
EP07820888A EP2073869A1 (en) | 2006-10-04 | 2007-10-03 | User interface for delivery system comprising diary function |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06121721.2 | 2006-10-04 | ||
EP06121721 | 2006-10-04 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2008040765A1 true WO2008040765A1 (en) | 2008-04-10 |
Family
ID=37907844
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/EP2007/060511 WO2008040765A1 (en) | 2006-10-04 | 2007-10-03 | User interface for delivery system comprising diary function |
Country Status (5)
Country | Link |
---|---|
US (1) | US8506524B2 (en) |
EP (1) | EP2073869A1 (en) |
JP (1) | JP2010506279A (en) |
CN (1) | CN101541360B (en) |
WO (1) | WO2008040765A1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018103008A (en) * | 2009-03-25 | 2018-07-05 | デカ・プロダクツ・リミテッド・パートナーシップ | Infusion pump methods and systems |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007000425A2 (en) * | 2005-06-27 | 2007-01-04 | Novo Nordisk A/S | User interface for delivery system providing graphical programming of profile |
CN101238464A (en) * | 2005-06-27 | 2008-08-06 | 诺沃-诺迪斯克有限公司 | User interface for delivery system providing shortcut navigation |
JP2008543518A (en) * | 2005-06-27 | 2008-12-04 | ノボ・ノルデイスク・エー/エス | Delivery system user interface with dual parameter setting |
US8652040B2 (en) | 2006-12-19 | 2014-02-18 | Valencell, Inc. | Telemetric apparatus for health and environmental monitoring |
US8157730B2 (en) | 2006-12-19 | 2012-04-17 | Valencell, Inc. | Physiological and environmental monitoring systems and methods |
US7935105B2 (en) * | 2007-09-07 | 2011-05-03 | Asante Solutions, Inc. | Data storage for an infusion pump system |
US8251903B2 (en) | 2007-10-25 | 2012-08-28 | Valencell, Inc. | Noninvasive physiological analysis using excitation-sensor modules and related devices and methods |
US8700111B2 (en) | 2009-02-25 | 2014-04-15 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US8788002B2 (en) | 2009-02-25 | 2014-07-22 | Valencell, Inc. | Light-guiding devices and monitoring devices incorporating same |
US9750462B2 (en) | 2009-02-25 | 2017-09-05 | Valencell, Inc. | Monitoring apparatus and methods for measuring physiological and/or environmental conditions |
US8888701B2 (en) | 2011-01-27 | 2014-11-18 | Valencell, Inc. | Apparatus and methods for monitoring physiological data during environmental interference |
WO2013016007A2 (en) | 2011-07-25 | 2013-01-31 | Valencell, Inc. | Apparatus and methods for estimating time-state physiological parameters |
EP2551784A1 (en) * | 2011-07-28 | 2013-01-30 | Roche Diagnostics GmbH | Method of controlling the display of a dataset |
EP3222210A1 (en) | 2011-08-02 | 2017-09-27 | Valencell, Inc. | Systems and methods for variable filter adjustment by heart rate metric feedback |
US10769924B2 (en) | 2012-03-08 | 2020-09-08 | Linquet Technologies Inc. | Comprehensive system and method of universal real-time linking of real objects to a machine, network, internet, or software service |
US8981938B2 (en) | 2012-03-08 | 2015-03-17 | Linquet Technologies, Inc. | Comprehensive system and method of universal real-time linking of real objects to a machine, network, internet, or software service |
USD677589S1 (en) | 2012-06-01 | 2013-03-12 | Deca International Corp. | Golf GPS device |
KR20140072737A (en) * | 2012-12-05 | 2014-06-13 | 삼성전자주식회사 | Display apparatus and Method for providing user menu thereof |
CN110013240A (en) | 2013-01-28 | 2019-07-16 | 瓦伦赛尔公司 | Physiological monitoring device with the sensing element disengaged with body kinematics |
US9357348B2 (en) | 2013-01-29 | 2016-05-31 | Tile, Inc. | Systems and methods for locating a tracking device |
USD723957S1 (en) | 2013-10-22 | 2015-03-10 | Tile, Inc. | Electronic tracking device |
EP3796332A1 (en) | 2013-11-14 | 2021-03-24 | Dexcom, Inc. | Devices and methods for continuous analyte monitoring |
US11145183B2 (en) | 2014-06-10 | 2021-10-12 | PB, Inc | Tracking device programs, systems and methods |
US10937286B2 (en) | 2014-06-10 | 2021-03-02 | Pb Inc. | Radiobeacon data sharing by forwarding low energy transmissions to a cloud host |
US9892626B2 (en) | 2014-06-10 | 2018-02-13 | Pb Inc. | Tracking device program |
US10979862B2 (en) | 2014-06-10 | 2021-04-13 | Pb Inc. | Tracking device system |
US11792605B2 (en) | 2014-06-10 | 2023-10-17 | PB, Inc. | Tracking device systems |
US9774410B2 (en) | 2014-06-10 | 2017-09-26 | PB, Inc. | Radiobeacon data sharing by forwarding low energy transmissions to a cloud host |
US10580281B2 (en) | 2014-06-10 | 2020-03-03 | PB, Inc. | Tracking device system |
US9538921B2 (en) | 2014-07-30 | 2017-01-10 | Valencell, Inc. | Physiological monitoring devices with adjustable signal analysis and interrogation power and monitoring methods using same |
EP4360552A3 (en) | 2014-08-06 | 2024-07-10 | Yukka Magic LLC | Optical physiological sensor modules with reduced signal noise |
US9794653B2 (en) | 2014-09-27 | 2017-10-17 | Valencell, Inc. | Methods and apparatus for improving signal quality in wearable biometric monitoring devices |
JP6438742B2 (en) * | 2014-11-13 | 2018-12-19 | テルモ株式会社 | Chemical solution administration device |
US10610158B2 (en) | 2015-10-23 | 2020-04-07 | Valencell, Inc. | Physiological monitoring devices and methods that identify subject activity type |
US10945618B2 (en) | 2015-10-23 | 2021-03-16 | Valencell, Inc. | Physiological monitoring devices and methods for noise reduction in physiological signals based on subject activity type |
US10361800B2 (en) | 2015-11-18 | 2019-07-23 | PB, Inc | Radiobeacon data sharing by forwarding low energy transmissions to a cloud host |
USD802453S1 (en) | 2016-05-09 | 2017-11-14 | Fitbit, Inc. | Flexible wristband accessory for a wearable fitness monitor |
US10966662B2 (en) | 2016-07-08 | 2021-04-06 | Valencell, Inc. | Motion-dependent averaging for physiological metric estimating systems and methods |
US11678141B2 (en) | 2018-09-18 | 2023-06-13 | Pb Inc. | Hybrid cellular Bluetooth tracking devices, methods and systems |
US11184858B2 (en) | 2018-09-18 | 2021-11-23 | PB, Inc. | Bluecell devices and methods |
WO2021050709A1 (en) * | 2019-09-10 | 2021-03-18 | Deka Products Limited Partnership | Medical device, method and system |
USD951107S1 (en) * | 2020-06-14 | 2022-05-10 | Xiamen Kangdong Technology Co, Ltd. | Digital watch case |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050022274A1 (en) * | 2003-04-18 | 2005-01-27 | Robert Campbell | User interface for infusion pump remote controller and method of using the same |
Family Cites Families (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4553958A (en) | 1983-02-04 | 1985-11-19 | Quest Medical, Inc. | IV Delivery controller |
US5249121A (en) | 1989-10-27 | 1993-09-28 | American Cyanamid Company | Remote control console for surgical control system |
US6018289A (en) * | 1995-06-15 | 2000-01-25 | Sekura; Ronald D. | Prescription compliance device and method of using device |
US7831930B2 (en) * | 2001-11-20 | 2010-11-09 | Universal Electronics Inc. | System and method for displaying a user interface for a remote control application |
US6554798B1 (en) | 1998-08-18 | 2003-04-29 | Medtronic Minimed, Inc. | External infusion device with remote programming, bolus estimator and/or vibration alarm capabilities |
DE19840965A1 (en) | 1998-09-08 | 2000-03-09 | Disetronic Licensing Ag | Device for self-administration of a product fluid |
KR20010081028A (en) | 1998-11-18 | 2001-08-25 | 추후제출 | Portable device and method for the mobile supply of medicaments with wireless transmission of data for control or programming purposes |
US8241270B2 (en) | 1999-04-30 | 2012-08-14 | Medtronic, Inc. | Drug infusion system and method adapted to start during programming cycle |
US6752787B1 (en) | 1999-06-08 | 2004-06-22 | Medtronic Minimed, Inc., | Cost-sensitive application infusion device |
US6423035B1 (en) | 1999-06-18 | 2002-07-23 | Animas Corporation | Infusion pump with a sealed drive mechanism and improved method of occlusion detection |
US6562001B2 (en) | 2000-01-21 | 2003-05-13 | Medtronic Minimed, Inc. | Microprocessor controlled ambulatory medical apparatus with hand held communication device |
US20030060765A1 (en) | 2000-02-16 | 2003-03-27 | Arthur Campbell | Infusion device menu structure and method of using the same |
US20010041869A1 (en) | 2000-03-23 | 2001-11-15 | Causey James D. | Control tabs for infusion devices and methods of using the same |
CN1335549A (en) | 2000-07-21 | 2002-02-13 | 骆忆黎 | Intuitive nine-check option input method for intelligent terminal |
US6589229B1 (en) | 2000-07-31 | 2003-07-08 | Becton, Dickinson And Company | Wearable, self-contained drug infusion device |
US6740059B2 (en) | 2000-09-08 | 2004-05-25 | Insulet Corporation | Devices, systems and methods for patient infusion |
US6875195B2 (en) | 2001-09-19 | 2005-04-05 | Soo Bong Choi | Portable automatic insulin syringe device with blood sugar measuring function |
US7204823B2 (en) | 2001-12-19 | 2007-04-17 | Medtronic Minimed, Inc. | Medication delivery system and monitor |
US20030212379A1 (en) | 2002-02-26 | 2003-11-13 | Bylund Adam David | Systems and methods for remotely controlling medication infusion and analyte monitoring |
US6744350B2 (en) | 2002-02-28 | 2004-06-01 | Smiths Medical Md, Inc. | Insulin pump having missed meal bolus alarm |
US6852104B2 (en) | 2002-02-28 | 2005-02-08 | Smiths Medical Md, Inc. | Programmable insulin pump |
US8250483B2 (en) | 2002-02-28 | 2012-08-21 | Smiths Medical Asd, Inc. | Programmable medical infusion pump displaying a banner |
US20040225252A1 (en) | 2002-06-14 | 2004-11-11 | John Gillespie | System and method for operating an infusion pump |
EP1391794A1 (en) | 2002-07-23 | 2004-02-25 | Novo Nordisk A/S | Device with time indicating means |
WO2004009160A1 (en) | 2002-07-24 | 2004-01-29 | M 2 Medical A/S | An infusion pump system, an infusion pump unit and an infusion pump |
CA2448315C (en) * | 2002-11-01 | 2019-01-08 | Cal/West Seeds | Alfalfa plants having improved standability and/or fast recovery after harvest and methods for producing same |
CA2515049A1 (en) * | 2003-02-14 | 2004-09-02 | Vesta L. Brue | Medication compliance device |
US20050182366A1 (en) | 2003-04-18 | 2005-08-18 | Insulet Corporation | Method For Visual Output Verification |
US20050055243A1 (en) | 2003-06-30 | 2005-03-10 | Dave Arndt | Method and apparatus for managing data received from a medical device |
JP4638694B2 (en) | 2003-08-21 | 2011-02-23 | テルモ株式会社 | Infusion device |
WO2005094919A1 (en) | 2004-03-30 | 2005-10-13 | Novo Nordisk A/S | Actuator system comprising detection means |
US20080188810A1 (en) | 2005-02-25 | 2008-08-07 | Novo Nordisk A/S | Pump Assembly With Safety Valve |
WO2007000425A2 (en) | 2005-06-27 | 2007-01-04 | Novo Nordisk A/S | User interface for delivery system providing graphical programming of profile |
EP1801718A1 (en) | 2005-12-21 | 2007-06-27 | F. Hoffmann-La Roche AG | Method for operating a computer controlled dosing device for liquid medicine in situations of travel time shift |
US20080171967A1 (en) * | 2006-10-17 | 2008-07-17 | Blomquist Michael L | Insulin pump having a food database |
-
2007
- 2007-10-03 JP JP2009530879A patent/JP2010506279A/en not_active Withdrawn
- 2007-10-03 CN CN200780037318.5A patent/CN101541360B/en not_active Expired - Fee Related
- 2007-10-03 WO PCT/EP2007/060511 patent/WO2008040765A1/en active Application Filing
- 2007-10-03 EP EP07820888A patent/EP2073869A1/en not_active Withdrawn
- 2007-10-03 US US12/443,868 patent/US8506524B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050022274A1 (en) * | 2003-04-18 | 2005-01-27 | Robert Campbell | User interface for infusion pump remote controller and method of using the same |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2018103008A (en) * | 2009-03-25 | 2018-07-05 | デカ・プロダクツ・リミテッド・パートナーシップ | Infusion pump methods and systems |
Also Published As
Publication number | Publication date |
---|---|
US8506524B2 (en) | 2013-08-13 |
CN101541360A (en) | 2009-09-23 |
EP2073869A1 (en) | 2009-07-01 |
CN101541360B (en) | 2013-04-10 |
JP2010506279A (en) | 2010-02-25 |
US20090326445A1 (en) | 2009-12-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US8506524B2 (en) | User interface for delivery system comprising diary function | |
US8395581B2 (en) | User interface for medical system comprising diary function with time change feature | |
US20130345666A1 (en) | User Interface for Delivery System Providing Dual Setting of Parameters | |
US20090018495A1 (en) | User Interface For Delivery System Providing Shortcut Navigation | |
US20080287922A1 (en) | User Interface for Delivery System Providing Graphical Programming of Profile | |
US6551276B1 (en) | External infusion device with remote programming bolus estimator and/or vibration alarm capabilities | |
US20050137530A1 (en) | Infusion device menu structure and method of using the same | |
US20110098637A1 (en) | Method and System for Configuring an Insulin Infusion Device | |
US20110098638A1 (en) | Sensor-Augmented Medication Infusion System | |
US20110098674A1 (en) | Method and System for Programming an Infusion Device | |
WO2009034100A1 (en) | User interface for displaying predicted values | |
WO2009112513A1 (en) | Drug delivery system with two communicating devices providing continuous drug delivery |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200780037318.5 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 07820888 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 1505/DELNP/2009 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2007820888 Country of ref document: EP |
|
ENP | Entry into the national phase |
Ref document number: 2009530879 Country of ref document: JP Kind code of ref document: A |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 12443868 Country of ref document: US |